![Gabriel Adusei](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Gabriel Adusei worked as a Manager of Quality & Regulatory Affairs at Endomagnetics Ltd.
He was also a Principal at Bsi and a Course Director at Cranfield University.
Adusei graduated from the University of Greenwich with a graduate degree and earned a doctorate from the University of King's College.
Former positions of Gabriel Adusei
Companies | Position | End |
---|---|---|
Cranfield University | Corporate Officer/Principal | 2009-12-31 |
Bsi
![]() Bsi Packaged SoftwareTechnology Services Part of UnitedHealth Group, Inc., Bsi is a business improvement company that enables organizations to turn standards of best practice into habits of excellence. The company is based in Herndon, VA. Bsi was acquired by Pharmacy Software Holdco, Inc. on October 26, 1999. Bsi's corporate mission is to "inspire trust and build a more resilient world." The company has over 86,000 customers in 193 countries/regions worldwide and offer expertise in various industries such as automotive, aerospace, construction, environment, food, retail, and healthcare. Bsi provides certification services, training, and regulatory services to help customers improve business performance for sustainable growth and effective risk management. The company has a proprietary R & D platform for sustainable and improved production of advanced botanical materials. The company's active ingredient, ABM-01, is used in their biopesticide Quillibrium® and the adjuvant QS-21, which is used in modern vaccine development. The company was founded in 1901. The CEO is Susan Taylor Martin. | Corporate Officer/Principal | 2008-12-31 |
Endomagnetics Ltd.
![]() Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Training of Gabriel Adusei
University of Greenwich | Graduate Degree |
University of King's College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Endomagnetics Ltd.
![]() Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
Bsi
![]() Bsi Packaged SoftwareTechnology Services Part of UnitedHealth Group, Inc., Bsi is a business improvement company that enables organizations to turn standards of best practice into habits of excellence. The company is based in Herndon, VA. Bsi was acquired by Pharmacy Software Holdco, Inc. on October 26, 1999. Bsi's corporate mission is to "inspire trust and build a more resilient world." The company has over 86,000 customers in 193 countries/regions worldwide and offer expertise in various industries such as automotive, aerospace, construction, environment, food, retail, and healthcare. Bsi provides certification services, training, and regulatory services to help customers improve business performance for sustainable growth and effective risk management. The company has a proprietary R & D platform for sustainable and improved production of advanced botanical materials. The company's active ingredient, ABM-01, is used in their biopesticide Quillibrium® and the adjuvant QS-21, which is used in modern vaccine development. The company was founded in 1901. The CEO is Susan Taylor Martin. | Technology Services |
- Stock Market
- Insiders
- Gabriel Adusei